1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends

Global Market Study on Insulin Delivery Devices: Asia to Witness Highest Growth by 2020

  • September 2014
  • 125 pages
  • Persistence Market Research
Report ID: 3175833

Summary

Table of Contents

Diabetes is a disease characterized by high blood sugar levels. It is caused by the improper functioning of the pancreas that secretes insulin. Insulin is a hormone that maintains blood sugar levels in the body and helps in the proper functioning of all cellular and physiological activities. Diabetes is more common in the aged population; however, incidence of diabetes is also increasing in children and adults. To overcome this problem, insulin delivery devices, such as insulin pens, pumps, syringes, and jet injectors, play a vital role in maintaining insulin levels in the body. Insulin pens, syringes, and pumps are devices that facilitate the delivery of insulin just under the skin through a needle.

Insulin syringes are designed for self-administration of doses and have many user-friendly features. For instance, these devices have short needles that are less painful for the patient. Insulin pen comprises insulin cartridge, dial and a needle. Insulin pen devices are used with disposable needles for the delivery of insulin doses. The compact design of these devices allows discreet administration of insulin. Insulin pens are of two types: prefilled and reusable. A prefilled pen is discarded once the contents of an insulin cartridge are administered, whereas a reusable pen contains replaceable insulin cartridges which are loaded and removed from the pen.

Insulin pump is composed of a pump, a disposable reservoir to hold the insulin, and a disposable infusion set, including cannula for subcutaneous insertion of doses. An insulin pump can be worn externally and clipped to wearer’s belt. Insulin jet injectors inject insulin without the use of any needle. Insulin jets are composed of three parts: a disposable injector nozzle, the delivery device shaped like a pen, and a disposable insulin vial adapter.

Globally, the increasing prevalence of diabetes and obesity are some major drivers for the growth of the market. In addition, advanced features of insulin delivery devices and rising awareness among people about diabetes care are also supporting the growth of the global insulin delivery devices market.

However, risk and complications associated with the delivery of insulin and high cost of insulin analog hamper the growth of the market. Artificial pancreas and home infusion therapy are some of the major trends of global insulin delivery devices market.

Under geographic analysis, North America dominates the global insulin delivery devices market due to increasing prevalence of diabetes and rising number of overweight and obese people. The U.S. represents the largest market for insulin delivery devices followed by Canada in North America. Germany, France, the U.K., Italy and Spain holds major share of insulin delivery devices market in Europe. However, Asia is the fastest growing region in the global insulin delivery devices market due to rising aging population. In addition, several government initiatives are increasing awareness about diabetes treatment which would increase the demand for insulin delivery devices in the region.

The global insulin delivery devices market report provides in-depth analysis and estimation of the insulin delivery devices market from 2014 to 2020, considering 2014 as the base year for calculation. Additionally, data pertaining to current market dynamics, including market drivers, restraints, trends, and recent developments, has been provided in the global insulin delivery devices market report.

Some of the major players operating in the market are Abbott Laboratories, Novo Nordisk A/S, Eli Lilly and Company, Medtronic, Inc., Sanofi, Becton, Dickinson and Company, and F. Hoffmann-La Roche, Ltd. These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability and financial overview.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021

  • $ 5650
  • Industry report
  • April 2017
  • by MarketsandMarkets

The insulin delivery devices market is projected to reach USD 17.85 billion by 2021 from USD 11.54 billion in 2016, growing at a CAGR of 9.1% in the next five years (2016 to 2021). Favorable reimbursement ...

Insulin Delivery Devices Market by Type, Insulin Pumps, Pen Needles, Insulin Syringes and End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • April 2017
  • by MarketsandMarkets

The insulin delivery devices market is projected to reach USD 17.85 billion by 2021 from USD 11.54 billion in 2016, growing at a CAGR of 9.1% in the next five years (2016 to 2021). Favorable reimbursement ...

Smart Insulin Pens Market: Bluetooth Connected Smart Insulin Pens Allow Effective Insulin Dose Management along with Data Sharing Capabilities: Global Industry Analysis and Opportunity Assessment 2017-2027

  • $ 5000
  • Industry report
  • April 2017
  • by Future Market Insight Global & Consulting Pvt Ltd

Bluetooth connected smart insulin pen segment to register highest market attractiveness index in the near future By connectivity, the Bluetooth connected smart insulin pen segment is expected to account ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.